Sponsor or institution

Clinical trials and research at CorMedix Therapeutics

• 2Clinical trials
• 2Countries

All recruiting trials (2)

• Comparing DEFENCATH® to Heparin for Preventing Infections in Patients on Total Parenteral Nutrition

  This study is testing whether a new solution called DEFENCATH® can better prevent infections in adults who are getting nutrition through a central line compared to the standard treatment with heparin.

  Recruiting at 22 sites Phase 3 CorMedix Therapeutics · Los Angeles, California and 23 other locations · NCT06822426

• Safety of DefenCath (taurolidine‑heparin) catheter lock in children on chronic hemodialysis

  This will test whether a taurolidine‑heparin catheter lock solution (DefenCath) is safe and delays catheter‑related bloodstream infections in children from birth to under 18 who are on chronic hemodialysis.

  Recruiting at 6 sites Phase 4 CorMedix Therapeutics · Birmingham, Alabama and 5 other locations · NCT06714864

Quick answers

How many clinical trials run by CorMedix Therapeutics are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 2 countries. The most sites are in United States (2 trials), Turkey (Türkiye) (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →